Details of the Drug

General Information of Drug (ID: DM3ZLTB)

• Drug Name: PVSRIPO

Indication

Disease Entry	ICD 11	Status	REF
Glioblastoma of brain	2A00.00	Phase 2	[1]
Melanoma	2C30	Phase 2	[2]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: DIWL76
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04479241) PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT04577807) LUMINOS-102: PVSRIPO With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma. U.S. National Institutes of Health.